 |
|
|
 |
An Adenovirus Vector To Reverse Hypercholesterolemia? And Other Stories From The American Society Of Gene Therapy
Gutless adenovirus or "helper-dependent" adenovirus (HD-Ad), an adenoviral vector devoid of all adenoviral genes except for the packaging signal necessary for proper formation, is safe and effective for in vivo gene delivery to the liver, according to researchers at the American Society of Gene Therapy Annual Meeting. more
|
|
Influenza Vaccine Continues To Be In Short Supply - Next Year's Supply In Jeopardy
America will continue to risk flu vaccine shortages as long as only a handful of companies produce the vaccine, health officials said Thursday. Last year's shortage occurred after the Food and Drug Administration ordered two of the nation's four flu vaccine makers to correct manufacturing problems in their factories, delaying production. more
|
|
|
|
Vitamin E Needed To Help Prevent Heart Disease - Typical American Doesn't Get Enough
Almost 30 percent of the US population has "dismally low" blood levels of Vitamin E, a leading health publication reported yesterday. Prevention magazine, in an article by writer Denise Webb and distributed to major daily newspapers by the New York Times Syndicate, said: "Because the evidence suggests that Vitamin E can protect your health without harmful side effects, Prevention magazine recommends that you consider a daily Vitamin E supplement of 100 to 400 IU (international units)." more
|
|
American Academy Of Pediatrics Says Looking At What Kids Drink May Help In Battle Against Childhood Obesity
Soda consumption has been linked to poor health and obesity in children. But, drinking too much fruit juice may also contribute to the rising rates of overweight children, according to a new policy statement released by the American Academy of Pediatrics (AAP). One in four children in this country is overweight or is at risk for becoming overweight. more
|
|
Topical Treatment Of Superficial Basal Cell Carcinoma Successfully Completes Phase II Clinical Trials With Promising Results
A study published in the current issue of Journal of American Academy of Dermatology (May 2001) reports an almost 90% clearance of superficial basal cell carcinoma (sBCC) following daily application of Aldara(TM) (imiquimod) 5% Cream for six weeks. Of the 33 patients in the once-daily regimen 87.9% showed complete clearance of their sBCC tumor. more
|
|
|
